A Randomized, Open-label Study to Evaluate the Immunogenicity of Anthrax Vaccine Adsorbed Alone or Concomitantly With Raxibacumab (GSK3068483)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 10 Jun 2017
At a glance
- Drugs Raxibacumab (Primary) ; Anthrax vaccine; Diphenhydramine; Diphenhydramine
- Indications Anthrax; Bacterial infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 20 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 27 Oct 2016 Planned End Date changed from 1 Apr 2017 to 1 Jun 2017.
- 19 Sep 2016 Planned End Date changed from 1 Aug 2017 to 1 Apr 2017.